Unibest 优贝德
登录 / 注册
← 返回专利悬崖列表

氯苯唑酸

Tier C · 观察 / 贸易

Tafamidis

辉瑞
原研
2019
首批上市
-
到期年(公开口径)
无销量数据
峰值销售
化学药
类型

靶点TTR

商品名维万心、VYNDAMAX

适应症(已批准)转甲状腺素运载蛋白淀粉样变性、心脏病

各地区研发/上市状态

美国
批准上市
2019-05-03
欧盟
临床一期
2024-02-27
中国
批准上市
2020-09-30
日本
临床一期
2026-05-11

合成路线与中间体8 routes

原研路线 × 0优化路线(非专利)× 8工艺路线 × 0

路线按「原研路线 → 优化路线 / 工艺路线(非专利)」排序。每条路线附本站自绘的路线流程图(中间体 → 原料药)与中间体表(编号 / CAS / 英文名),可直接用于供应商开发与询价。流程图由本站依据已授权的结构化数据自行渲染,未使用任何第三方路线图。

优化Route 1步骤 5 · 总收率 /
合成路线与中间体 Route 1
编号CAS 号中间体名称
(I)409139-2-a2374-03-0(4-Carboxy-2-hydroxyphenyl)amine
(II)409139-2-a149-73-5Orthoformic acid trimethyl ester
(III)409139-2-a-1,3-Benzoxazole-6-carboxylic acid
(IV)409139-2-a-1,3-Benzoxazole-6-carbonyl chloride
(V)409139-2-a1334429-35-41,3-Benzoxazol-6-yl(morpholin-4-yl)methanone
(VI)409139-2-a3032-81-31,3-Dichloro-5-iodobenzene
(VII)409139-2-a-[2-(3,5-Dichlorophenyl)-1,3-benzoxazol-6-yl]-morpholinomethanone
(VIII)409139-2-a594839-88-02-(3,5-Dichlorophenyl)benzo[d]oxazole-6-carboxylic acid
优化Route 2步骤 4 · 总收率 /
合成路线与中间体 Route 2
编号CAS 号中间体名称
(I)409139-3-a2905-62-63,5-Dichloro-1-benzenecarbonyl chloride
(II)409139-3-a1624066-48-33,5-Dichloro-N-methyl-N-phenylbenzamide
(III)409139-3-a2650595-66-5N-[(3,5-Dichlorophenyl)(methoxy)methylidene]-N-methylbenzeniminium trifluoromethanesulfonate
(IV)409139-3-a1692797-15-11,3-Dichloro-5-(trimethoxymethyl)benzene
(V)409139-3-a4704-99-82-(Hydroxymethyl)-2-phenylpropane-1,3-diol
(VI)409139-3-a122-78-12-Phenylacetaldehyde
(VII)409139-3-a77-99-62-Ethyl-2-(hydroxymethyl)propane-1,3-diol
(VIIIa)409139-3-a2650595-70-11-(3,5-Dichlorophenyl)-4-phenyl-2,6,7-trioxabicyclo[2.2.2]octane
(VIIIb)409139-3-a2650595-69-81-(3,5-Dichlorophenyl)-4-ethyl-2,6,7-trioxabicyclo[2.2.2]octane
(IX)409139-3-a2374-03-0(4-Carboxy-2-hydroxyphenyl)amine
(X)409139-3-a594839-88-02-(3,5-Dichlorophenyl)benzo[d]oxazole-6-carboxylic acid
优化Route 3步骤 3 · 总收率 /
合成路线与中间体 Route 3
编号CAS 号中间体名称
(I)409139-4-a2905-62-63,5-Dichloro-1-benzenecarbonyl chloride
(II)409139-4-a3143-02-0(3-Methyloxetan-3-yl)methanol
(III)409139-4-a2650595-67-6(3-Methyloxetan-3-yl)methyl 3,5-dichlorobenzoate
(IV)409139-4-a2650595-68-71-(3,5-Dichlorophenyl)-4-methyl-2,6,7-trioxabicyclo[2.2.2]octane
(V)409139-4-a2374-03-0(4-Carboxy-2-hydroxyphenyl)amine
(VI)409139-4-a594839-88-02-(3,5-Dichlorophenyl)benzo[d]oxazole-6-carboxylic acid
优化Route 4步骤 3 · 总收率 /
合成路线与中间体 Route 4
编号CAS 号中间体名称
(Ia)409139-5-a590-86-33-Methylbutanal
(Ib)409139-5-a2987-16-83,3-Dimethylbutanal
(IIa)409139-5-a20762-78-12-(Hydroxymethyl)-2-(propan-2-yl)propane-1,3-diol
(IIb)409139-5-a67590-29-82-tert-Butyl-2-(hydroxymethyl)propane-1,3-diol
(III)409139-5-a51-36-53,5-Dichlorobenzoic acid
(IVa)409139-5-a2650595-75-61-(3,5-Dichlorophenyl)-4-(propan-2-yl)-2,6,7-trioxabicyclo[2.2.2]octane
(IVb)409139-5-a2650595-77-84-tert-Butyl-1-(3,5-dichlorophenyl)-2,6,7-trioxabicyclo[2.2.2]octane
(V)409139-5-a2374-03-0(4-Carboxy-2-hydroxyphenyl)amine
(VI)409139-5-a594839-88-02-(3,5-Dichlorophenyl)benzo[d]oxazole-6-carboxylic acid
优化Route 5步骤 2 · 总收率 /
合成路线与中间体 Route 5
编号CAS 号中间体名称
(I)409139-6-a1692797-15-11,3-Dichloro-5-(trimethoxymethyl)benzene
(II)409139-6-a3068-00-6(±)-1,2,4-Butanetriol
(III)409139-6-a2650595-73-41-(3,5-Dichlorophenyl)-2,7,8-trioxabicyclo[3.2.1]octane
(IV)409139-6-a107-21-1在售1,2-Dihydroxyethane
(V)409139-6-a2650595-72-32-(3,5-Dichlorophenyl)-2-methoxy-1,3-dioxolane
(VI)409139-6-a2041-15-8cis-Cyclohexane-1,3,5-triol
(VII)409139-6-a2650595-74-53-(3,5-Dichlorophenyl)-2,4,10-trioxaadamantane
(VIII)409139-6-a2374-03-0(4-Carboxy-2-hydroxyphenyl)amine
(IX)409139-6-a594839-88-02-(3,5-Dichlorophenyl)benzo[d]oxazole-6-carboxylic acid
优化Route 6步骤 2 · 总收率 /
合成路线与中间体 Route 6
编号CAS 号中间体名称
(Ia)409139-7-a10203-08-4在售3,5-Dichlorobenzaldehyde
(Ib)409139-7-a51-36-53,5-Dichlorobenzoic acid
(IIa)409139-7-a2835-98-52-Amino-5-methylphenol
(IIb)409139-7-a182499-90-71-Amino-2-hydroxy-4-ethylbenzene
(IIc)409139-7-a2316835-58-02-Amino-5-butylphenol
(IId)409139-7-a2374-03-0(4-Carboxy-2-hydroxyphenyl)amine
(IIIa)409139-7-a1414840-15-52-(3,5-Dichlorophenyl)-6-methyl-1,3-benzoxazole
(IIIb)409139-7-a2761347-26-42-(3,5-Dichlorophenyl)-6-ethyl-1,3-benzoxazole
(IIIc)409139-7-a2761347-28-66-Butyl-2-(3,5-dichlorophenyl)-1,3-benzoxazole
(IV)409139-7-a594839-88-02-(3,5-Dichlorophenyl)benzo[d]oxazole-6-carboxylic acid
(V)409139-7-a-4-([(1E)-(3,5-Dichlorophenyl)methylene]amino)-3-hydroxybenzoic acid
优化Route 7步骤 2 · 总收率 /
合成路线与中间体 Route 7
编号CAS 号中间体名称
(I)409139-9-a-1-Ethyl-3-hydroxybenzene
(II)409139-9-a39989-43-0(3,5-Dichlorophenyl)methanamine
(III)409139-9-a2761347-26-42-(3,5-Dichlorophenyl)-6-ethyl-1,3-benzoxazole
(IV)409139-9-a594839-88-02-(3,5-Dichlorophenyl)benzo[d]oxazole-6-carboxylic acid
(V)409139-9-a17159-79-44-Oxocyclohexanecarboxylic acid ethyl ester
(VI)409139-9-a-Ethyl 2-(3,5-dichlorophenyl)-1,3-benzoxazole-6-carboxylate
优化Route 8步骤 4 · 总收率 /
合成路线与中间体 Route 8
编号CAS 号中间体名称
(I)409139-12-a626-43-73,5-Dichloroaniline
(II)409139-12-a431-03-82,3-Butanedione
(III)409139-12-a14401-72-01-(3,5-Dichlorophenyl)ethanone
(IV)409139-12-a-(3,5-Dichlorophenyl)(oxo)acetic acid
(V)409139-12-a2835-98-52-Amino-5-methylphenol
(VI)409139-12-a1414840-15-52-(3,5-Dichlorophenyl)-6-methyl-1,3-benzoxazole
(VII)409139-12-a594839-88-02-(3,5-Dichlorophenyl)benzo[d]oxazole-6-carboxylic acid

常见问题(FAQ)

氯苯唑酸的适应症有哪些?

已批准的适应症包括:转甲状腺素运载蛋白淀粉样变性、心脏病。

氯苯唑酸的专利什么时候到期?

氯苯唑酸的专利到期年暂无公开口径,本页会在数据管道核实后更新。

氯苯唑酸有几条合成路线?

本站收录 8 条合成路线,最短路线 2 步、总收率 /。每条路线的中间体均带登记编号与 CAS 号。

氯苯唑酸的关键中间体在哪里可以采购?

氯苯唑酸的多条路线中间体已挂接 CAS 档案,其中 2 个 CAS 已有优贝德(Unibest)供应网络在售报价,可在本页路线表中直接查看并询价。

如何获取氯苯唑酸中间体的报价?

在本页选择目标中间体的 CAS 进入档案页,或在询价页直接提交需求;CAS 会自动带入供需撮合流程,由供应网络反馈报价。

数据来源:多源数据交叉核实(仅结构化字段) · 2026-09-24